Nadya BradyFounder at LuminaBio AdvisorySpeaker
Profile
Nadya Brady is Founder and Managing Director of LuminaBio Advisory, where she advises life sciences companies on oligonucleotide CMC, regulatory strategy, analytical control strategy, and external development and manufacturing partnerships. With more than 20 years of experience across small and large pharma and biotech organizations, including GSK, GreenLight Bio, and Nitto Denko Avecia, she supports teams navigating development, operational readiness, and commercialization strategy for innovative therapies.
Agenda Sessions
Oligonucleotide CMC Across the Product Lifecycle: From Preclinical to Market
, 09:00View Session

